You are here

Home » Content

Ailesel hiperkolesterolemi ile birlikte diffüz asendan aorta ve sol ana koroner arter tutulumu: Olgu Sunumu

Diffuse involvement of ascending aorta and left main coronary artery with familial hypercholesterolemia: Case Report

Journal Name:

  • Süleyman Demirel Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi

Publication Year:

  • 2013

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Familial hypercholesterolemia (FH) is an inherited genetic disorder leading to increased plasma LDL levels due to defects in LDL-cholesterol metabolism. Atherosclerosis occurs early due to the high serum lipid levels and inability to eliminate LDL-cholesterol from circulation. This results in coronary artery disease and atherosclerotic aorta at early age. Atheromatous alterations in aortic root lead to coronary osteal lesions and irregularities in the inner aortic wall. We present an FH case with extensive involvement of ascending aorta with coronary ostial lesion
Bookmark/Search this post with
Abstract (Original Language): 
Ailesel hiperkolesterolemi (AH) ailesel geçiş gösteren, LDL-kolesterol metabolizmasındaki bozukluk sonucu plazma LDL düzeyinde artışa neden olan genetik bir hastalıktır. Yüksek serum lipid düzeyi ve LDL-kolesterolün dolaşımdan temizlenememesi nedeniyle hızlı ateroskleroz gelişimi vardır. Bu da erken yaşta koroner arter hastalığı ve aterosklerotik aort oluşumuna neden olur. Aort kökündeki ateromatöz değişiklikler koroner osteal lezyonlara ve aort iç duvarında düzensizliklere yol açmaktadır. Biz de koroner osteal lezyonla birlikte asendan aorta da yaygın tutulumu olan AH’li bir vakayı sunuyoruz.
FULL TEXT (PDF): 
PDF icon arastirmax-ailesel-hiperkolesterolemi-ile-birlikte-diffuz-asendan-aorta-sol-ana-koroner-arter-tutulumu-olgu-sunumu.pdf
  • 3
122
124
  • Turkish

REFERENCES

References: 

1. Harada-Shiba M, Arai H, Oikawa S, et al. Guidelines for the management of familial hypercholesterolemia. J Atheroscler Thromb. 2012; 19(12): 1043-1060.
2. Kawaguchi A, Miyatake K, Yutani C, Beppu S, Tsushima M, Yamamura T, Yamamoto A. Characteristic cardiovascular
manifestation in homozygous and heterozygous familial hypercholesterolemia. Am Heart J. 1999; 137(3): 410-418.
3. Jehlicka P, Stozicky F, Mayer O, et al. Asymmetric dimethylarginine and the effect of folate substitution in children with familial hypercholesterolemia and diabetes mellitus type 1. Physiol Res. 2009; 58(2): 179-184.4. Alrasadi K, Alwaili K, Awan Z, Valenti D, Couture P, Genest J. Aortic calcifications in familial hypercholesterolemia: potential role of the low-density lipoprotein receptor gene. Am Heart J. 2009; 157(1): 170-176.
5. Pietroleonardo L, Ruzicka T. Skin manifestations in familial heterozygous hypercholesterolemia. Acta Dermatovenerol Alp Panonica Adriat. 2009; 18(4): 183-187.
6. Yuan G, Wang J, Hegele RA. Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease. CMAJ. 2006; 174(8): 1124-1129.

Thank you for copying data from http://www.arastirmax.com